← Back to Clinical Trials
Recruiting NCT06916286

NCT06916286 Evaluating the Effect of Surgical Drain Securement on Patient Quality of Life and Postoperative Drain-related Complications

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06916286
Status Recruiting
Phase
Sponsor Wake Forest University Health Sciences
Condition Surgical Drain
Study Type INTERVENTIONAL
Enrollment 140 participants
Start Date 2025-05-05
Primary Completion 2027-05-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
K-LockSuture

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 140 participants in total. It began in 2025-05-05 with a primary completion date of 2027-05-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The objective of this study is to evaluate whether surgical drain securement with a novel sutureless device (K-LOCKTM) will improve patient quality of life and reduce postoperative drain-related complications compared to drain securement with traditional suture-based methods. The K-LOCK™ Device is a novel sutureless drain securement device that may improve patient experiences with surgical drains.

Eligibility Criteria

Inclusion Criteria: * Age 18 years or older * Patient of the Department of Plastic and Reconstructive Surgery * Able to sign English language Consent form * Undergoing a surgical procedure where placement of one or more surgical drains is anticipated Exclusion Criteria: * Unable to sign English language consent form * Incompatible drain size placed * Allergy or sensitivity to skin adhesives

Contact & Investigator

Central Contact

Renea D Jennings, BSN,RN,CCRP

✉ renea.jennings@advocatehealth.org

📞 336-716-6709

Principal Investigator

Bennett W Calder, MD

PRINCIPAL INVESTIGATOR

Wake Forest University Health Sciences

Frequently Asked Questions

Who can join the NCT06916286 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Surgical Drain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06916286 currently recruiting?

Yes, NCT06916286 is actively recruiting participants. Contact the research team at renea.jennings@advocatehealth.org for enrollment information.

Where is the NCT06916286 trial being conducted?

This trial is being conducted at Winston-Salem, United States.

Who is sponsoring the NCT06916286 clinical trial?

NCT06916286 is sponsored by Wake Forest University Health Sciences. The principal investigator is Bennett W Calder, MD at Wake Forest University Health Sciences. The trial plans to enroll 140 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology